Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 6/20 | 0.45 |
| ▸ | AHR | P35869 | 3/20 | 0.45 |
| ▸ | PAX8 | Q06710 | 2/20 | 0.45 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | FYN | P06241 | 1/20 | 0.45 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | HNF4A | P41235 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10122694 | 0.98 | ABCG2 (0.46) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL22217510 | 0.95 | ABCG2 (0.49) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL22218984 | 0.95 | KDM4E (0.44) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL22217512 | 0.95 | ABCG2 (0.42) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL20127294 | 0.95 | ABCG2 (0.44) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL20127292 | 0.94 | TDP1 (0.44) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL20127306 | 0.94 | KDM4E (0.45) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL10122503 | 0.94 | ABCG2 (0.50) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL10122506 | 0.94 | ABCG2 (0.43) | ABCG2AHRPAX8CYP1A1CYP1A2 | |
| SCHEMBL22218986 | 0.93 | ABCG2 (0.40) | ABCG2AHRPAX8CYP1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200227658-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-07-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200227658-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | PIEZO1, OCIAD1, SLCO4C1 | ABCG2 2377/4885AHR 3647/4885PAX8 2423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.